We do not offer telephone consultations. Please contact us via email or live chat.
© 2026 Together Clinic
Semaglutide · Once Weekly
Wegovy (semaglutide) is a once-weekly injection specifically approved for weight management. Clinical trials show patients lose up to 20.7% of their body weight. Food and Drug Administration (FDA) and Medicines and Healthcare products Regulatory Agency (MHRA) approved with proven cardiovascular benefits.
Up to 20.7% body weight loss in clinical trials
Once-weekly injection — simple and convenient
Reduces cardiovascular risk by 20% in clinical studies
Tracked, discreet delivery with ongoing support
Gradual & Personalised
Your body adjusts to semaglutide over the first 4 weeks.
First increase — appetite changes typically begin.
Many patients achieve significant results at this dose.
Continued increase if clinically appropriate.
Full maintenance dose for optimal weight loss.
Important: Personalised Dosing — Not everyone needs the highest dose. Your prescriber will recommend the right dose based on your individual response.
Start Today
Start with a short online assessment, reviewed by a UK-registered prescriber.
Start Journey